SLAM
MIRM icon

Swiss Life Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Swiss Life Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$358K Sell
3,056
-1,350
-31% -$136K ﹤0.01% 1145
2026
Q1 		$407K Buy
4,406
+354
+9% +$33.3K ﹤0.01% 963
2025
Q4 		$320K Buy
+4,052
New +$291K ﹤0.01% 990

Other funds holding MIRM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Swiss Life Asset Management's MIRM Position: Q2 2026 in Review

Swiss Life Asset Management reduced its Mirum Pharmaceuticals (MIRM) stake by 31% in Q2 2026, selling an estimated $136K and leaving 3,056 shares worth $358K. The position accounts for ﹤0.01% of the portfolio, ranked #1145.

Swiss Life Asset Management first reported a position in MIRM in Q4 2025 and has held it in 3 quarters since. The position peaked at $407K in Q1 2026. 212 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Swiss Life Asset Management held 3,056 shares of Mirum Pharmaceuticals worth $358K as of Q2 2026.
  • Swiss Life Asset Management sold 1,350 Mirum Pharmaceuticals shares in Q2 2026, an estimated $136K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #1145 holding.
  • Swiss Life Asset Management first reported a position in Mirum Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Swiss Life Asset Management's Mirum Pharmaceuticals position peaked at $407K in Q1 2026.
  • 212 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.